$MGX
Metagenomi Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$1.10
▼-2.65%-$0.030
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateMetagenomi Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is MGX down today? It is at $1.10 (-2.65%), and our scanner flagged it 2 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment MGX spikes, and full due diligence on MGX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $MGX 2 times in the last 30 days. Create a free account to track $MGX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on MGX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for MGX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Reid Laurence Director | Bought (open market) | +20K 0.05% of company | n/a | 20K | $23K at $1.17 | Sep 9, 26 |
Wapnick Pamela Officer | Sold (automatic/other) | -2K | sold 0.9% | 207K | $2K at $1.16 | Sep 8, 26 |
Irish Jian Officer | Sold (automatic/other) | -2K | sold 0.6% | 375K | $2K at $1.16 | Sep 8, 26 |
Wein Matthew Officer | Sold (automatic/other) | -358 | sold 0.3% | 126K | $415 at $1.16 | Sep 8, 26 |
Wein Matthew Officer | Sold (automatic/other) | -558 | sold 0.4% | 126K | $725 at $1.30 | Jun 5, 26 |
Irish Jian Officer | Sold (automatic/other) | -4K | sold 1.0% | 378K | $5K at $1.30 | Jun 5, 26 |
Wapnick Pamela Officer | Sold (automatic/other) | -3K | sold 1.4% | 208K | $4K at $1.30 | Jun 5, 26 |
Wapnick Pamela Officer | Acquired (grant/award) | +24K 0.06% of company | added 13% | 211K | n/a | Apr 1, 26 |
Wein Matthew Officer | Acquired (grant/award) | +11K 0.03% of company | added 9.6% | 126K | n/a | Apr 1, 26 |
Irish Jian Officer | Acquired (grant/award) | +46K 0.1% of company | added 14% | 380K | n/a | Apr 1, 26 |
Irish Jian Officer | Sold (automatic/other) | -2K | sold 0.5% | 334K | $3K at $1.60 | Mar 5, 26 |
Wein Matthew Officer | Sold (automatic/other) | -482 | sold 0.4% | 115K | $771 at $1.60 | Mar 5, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on MGX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for MGX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
MGX last traded at $1.10, down 2.65% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Metagenomi Therapeutics, Inc. Common Stock (MGX) is next expected to report earnings on Tuesday, November 10, 2026, about 51 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The MGX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged MGX 2 times in the last 30 days.
MGX (Metagenomi Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $42M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge MGX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$MGX discussion
Sign in to ask a question or join the discussion.